收藏切换
The current research status and progress in universal chimeric antigen receptor T-cell immunotherapy
收藏切换
Fang-ming ZHU, Xiao-qing CAI, Chang CUI, Hong-xi GUO, Ting-ting LU, Dao-jun XU
Chinese Journal of New Drugs | 2021, 30(13) : 1192 - 1199
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(13): 1192-1199
The current research status and progress in universal chimeric antigen receptor T-cell immunotherapy
Full
Fang-ming ZHU, Xiao-qing CAI, Chang CUI, Hong-xi GUO, Ting-ting LU, Dao-jun XU
Affiliations
  • Cytocraft Biopharmaceutical Co., Ltd., Kunming 650000, China
Published: 2021-07-15
Outline
收藏切换

Universal CAR-T cell technology belongs to the universal T cell technology based on gene editing in general CAR-T. It knocks out the signal receptor factor of T cell through gene editing, and produces CAR-T cell by using modified T cell from healthy volunteers; therefore it will not cause immune rejection such as graft versus host disease (GvHD) and host versus graft reaction (HvGR) after infusion. In animal experiments and early clinical trials, UCAR-T technology shows significant anti-tumor effect, wide applicability and tremendous application potentials. In terms of industrialization, UCAR-T cell technology is expected to solve the problems of high cost in designing and culturing autologous CAR-T preparations, of long preparation cycle, difficult quality control, insufficient cell quantity and expansion capacity, because of its unique features such as quality controllable, off-the-shelf, and easy for large-scale preparation, etc. This paper introduces the current research progress and existing problems of UCAR-T cells, and conducts a preliminary analysis of the existing problems, providing a reference for the fundamental research and clinical trials of UCAR-T cells.

universal CAR-T  /  tumor adoptive immunotherapy  /  genome editing  /  zinc-finger nucleases (ZFNs)  /  transcription activator-like effector nucleases (TALENs)  /  CRISPR/Cas9
朱芳明, 蔡晓晴, 崔畅, 郭虹汐, 陆婷婷, 徐道俊. 通用型嵌合抗原受体T细胞的研究现状及进展. 中国新药杂志, 2021 , 30 (13) : 1192 -1199 .
Fang-ming ZHU, Xiao-qing CAI, Chang CUI, Hong-xi GUO, Ting-ting LU, Dao-jun XU. The current research status and progress in universal chimeric antigen receptor T-cell immunotherapy[J]. Chinese Journal of New Drugs, 2021 , 30 (13) : 1192 -1199 .
Year 2021 volume 30 Issue 13
30
4
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-30
  • Published:2021-07-15
Article Data
Affiliations
History
  • Accepted:2020-12-01
Affiliations
    Cytocraft Biopharmaceutical Co., Ltd., Kunming 650000, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT